Picture of China Resources Pharmaceutical logo

3320 — China Resources Pharmaceutical News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

Brief: China Resources Pharmaceutical Group Says HY Revenue Rmb2.17 Billion For Jiangzhong Pharmaceutical

Aug 21 (Reuters) - China Resources Pharmaceutical Group
Ltd  3320.HK :
    * HY REVENUE RMB2.17 BILLION, DOWN 8.02% FOR JIANGZHONG
PHARMACEUTICAL
    * HY NET PROFIT ATTRIBUTABLE RMB488.8 MILLION FOR JIANGZHONG
PHARMACEUTICAL, UP 8.66%

Further company coverage:  3320.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on China Resources Pharmaceutical

See all news